Enveric Biosciences Inc vs SYSCO Corporation — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while SYSCO Corporation trades at $84.25 (market cap $40.32B). The key difference: SYSCO Corporation is far larger — about 6503.2× Enveric Biosciences Inc's market cap, and SYSCO Corporation pays a 2.61% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | SYY | |
|---|---|---|
Market Cap | $6.20M | $40.32B |
Sector | Health | Consumer Staples |
52-Week High | $17.40 | $91.16 |
52-Week Low | $1.27 | $69.30 |
Enterprise Value | $1.30M | $53.50B |
Dividend Yield | — | 2.61% |
Trailing returns across standard periods
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Sysco is the largest U.S. food-service distributor, boasting 17% market share of the highly fragmented food-service distribution industry. Sysco distributes over 400,000 food and nonfood products to restaurants (63% of revenue), healthcare facilities (8%), education and government buildings (8%), travel and leisure (7%), and other locations (14%) where individuals consume away-from-home meals. In fiscal 2022, 82% of the firm's revenue was U.S.-based, with 7% from Canada, 4% from the U.K., 2% from France, and 4% other.
Read more on SYY →